These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27574672)

  • 1. The molecular basis of hypertrophic scars.
    Zhu Z; Ding J; Tredget EE
    Burns Trauma; 2016; 4():2. PubMed ID: 27574672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Features of Hypertrophic Scars After Thermal Injury: Is There a Biologic Basis for Laser Therapy?
    Schaffrick L; Ding J; Kwan P; Tredget EE
    Adv Wound Care (New Rochelle); 2022 Apr; 11(4):163-178. PubMed ID: 34663086
    [No Abstract]   [Full Text] [Related]  

  • 3. The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo.
    Ding J; Ma Z; Liu H; Kwan P; Iwashina T; Shankowsky HA; Wong D; Tredget EE
    Wound Repair Regen; 2014; 22(5):622-30. PubMed ID: 25139227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Biology of Extracellular Matrix Proteins in Hypertrophic Scarring.
    Eremenko E; Ding J; Kwan P; Tredget EE
    Adv Wound Care (New Rochelle); 2022 May; 11(5):234-254. PubMed ID: 33913776
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.
    Honardoust D; Kwan P; Momtazi M; Ding J; Tredget EE
    Methods Mol Biol; 2013; 1037():203-31. PubMed ID: 24029937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural behavior of mononuclear phagocytes in HTS formation.
    Zhu Z; Ding J; Ma Z; Iwashina T; Tredget EE
    Wound Repair Regen; 2016; 24(1):14-25. PubMed ID: 26519112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS).
    Ding J; Hori K; Zhang R; Marcoux Y; Honardoust D; Shankowsky HA; Tredget EE
    Wound Repair Regen; 2011; 19(5):568-78. PubMed ID: 22092795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic depletion of macrophages in the subacute phase of wound healing reduces hypertrophic scar formation.
    Zhu Z; Ding J; Ma Z; Iwashina T; Tredget EE
    Wound Repair Regen; 2016 Jul; 24(4):644-56. PubMed ID: 27169512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Indirect Roles of Macrophages in Hypertrophic Scar Formation.
    Feng Y; Sun ZL; Liu SY; Wu JJ; Zhao BH; Lv GZ; Du Y; Yu S; Yang ML; Yuan FL; Zhou XJ
    Front Physiol; 2019; 10():1101. PubMed ID: 31555142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring.
    Honardoust D; Ding J; Varkey M; Shankowsky HA; Tredget EE
    J Burn Care Res; 2012; 33(5):668-77. PubMed ID: 22210076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications.
    Lian N; Li T
    Biomed Pharmacother; 2016 Dec; 84():42-50. PubMed ID: 27636511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
    Hsu KC; Luan CW; Tsai YW
    Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.